Literature DB >> 31840803

Nrf2 expression driven by Foxp3 specific deletion of Keap1 results in loss of immune tolerance in mice.

Patricia Klemm1, Anandhi Rajendiran1, Athanassios Fragoulis2, Christoph Wruck2, Angela Schippers1, Norbert Wagner1, Tobias Bopp3, Klaus Tenbrock1, Kim Ohl1.   

Abstract

The transcription factor Nrf2 regulates oxidative stress responses. However, the specific function of Nrf2 in Tregs, the central regulators of immune homeostasis, is unclear. Here, we report an unexpected but important role of Nrf2 in Tregs. Nrf2 expression driven by Foxp3 specific deletion of Keap1 resulted in an autoinflammatory phenotype with enhanced effector T cell activation and immune cell infiltrates in the lung. While early postnatal death of mice with Foxp3 specific deletion of Keap1 was most probably due to ectopic Foxp3cre expression and subsequent Keap1 deletion in epithelial cells, bone marrow chimeras suggest that Nrf2 activation intrinsically in Tregs contributes to a loss of Treg cells and diminished peripheral tolerance. Moreover, Nrf2 activation was associated with a loss of Foxp3 expression, but an enhanced glucose uptake and mTOR activity in Tregs, thus mimicking a metabolic phenotype that is associated with impaired lineage stability and cell functioning.
© 2019 The Authors. European Journal of Immunology published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Nrf2; immune tolerance; redox metabolism; regulatory T cells

Year:  2020        PMID: 31840803     DOI: 10.1002/eji.201948285

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Virus Infection Induces Keap1 Binding to Cytokine Genes, Which Recruits NF-κB p50 and G9a-GLP and Represses Cytokine Transcription.

Authors:  Veronica Elizabeth Burns; Tom Klaus Kerppola
Journal:  J Immunol       Date:  2021-08-16       Impact factor: 5.422

2.  Keap1 moderates the transcription of virus induced genes through G9a-GLP and NFκB p50 recruitment.

Authors:  Veronica Elizabeth Burns; Tom Klaus Kerppola
Journal:  Immunology       Date:  2022-07-07       Impact factor: 7.215

Review 3.  CD8+ T regulatory cells in lupus.

Authors:  Ram P Singh; David S Bischoff; Bevra H Hahn
Journal:  Rheumatol Immunol Res       Date:  2021-12-15

4.  Chronic arsenic exposure induces the time-dependent modulation of inflammation and immunosuppression in spleen.

Authors:  Nan Yan; Guowei Xu; Chenchen Zhang; Xuping Liu; Xin Li; Lin Sun; Da Wang; Xiaoxu Duan; Bing Li
Journal:  Cell Biosci       Date:  2020-07-30       Impact factor: 7.133

Review 5.  Oxidative Stress in SLE T Cells, Is NRF2 Really the Target to Treat?

Authors:  Kim Ohl; Klaus Tenbrock
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

Review 6.  Recent Advances in Understanding Nrf2 Agonism and Its Potential Clinical Application to Metabolic and Inflammatory Diseases.

Authors:  Min-Ji Kim; Jae-Han Jeon
Journal:  Int J Mol Sci       Date:  2022-03-05       Impact factor: 5.923

Review 7.  The Potential of Nrf2 Activation as a Therapeutic Target in Systemic Lupus Erythematosus.

Authors:  Michelle T Barati; Dawn J Caster
Journal:  Metabolites       Date:  2022-02-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.